The global cutting balloons market was valued at US$ 400.2 Million in 2022 and is expected to reach US$ 725.9 Million by 2033. The drug-coated cutting balloons products with around 42.1% value share, have topped the global market within the product in 2022 and are expected to grow at a CAGR of close to 6.0% over the forecast period (2023 to 2033)
Key Market Attributes
| Market Size, 2022 | US$ 400.2 Million |
|---|---|
| Market Size, 2023 | US$ 421.2 Million |
| Market Size, 2033 | US$ 725.9 Million |
| Value CAGR (2023 to 2033) | 5.6% |
The cutting balloons market refers to the medical devices used in minimally invasive procedures to treat arterial blockages. These balloons have small blades or microtomes attached to their surface, enabling precise cutting of plaque within arteries. The market is projected to experience substantial growth in the next decade due to rising cases of cardiovascular diseases and the increasing adoption of minimally invasive procedures.
Technological advancements and improved efficacy of cutting balloons are expected to drive demand. Additionally, the growing aging population and the focus on improving healthcare infrastructure worldwide will likely contribute to the market's expansion, addressing the rising need for effective vascular treatments.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for cutting balloons was around 2.3% of the overall US$ 17.5 Billion of the global interventional cardiology devices market in 2022.
Semi Annual Market Update
| Particular | Value CAGR |
|---|---|
| H1 | 4.90% (2022 to 2032) |
| H2 | 6.22% (2022 to 2032) |
| H1 | 5.36% (2023 to 2033) |
| H2 | 5.82% (2023 to 2033) |
The cutting balloon market has witnessed significant growth from 2017 to 2022 due to its unique advantages in percutaneous coronary interventions. Unlike traditional methods, the cutting balloon reduces vessel stretch and injury by scoring the vessel longitudinally, leading to controlled disruption of atherosclerotic plaque. This innovative approach has garnered attention as it minimizes risks associated with vessel damage.
However, the market outlook for 2023 to 2033 indicates a continued upward trajectory due to growing awareness of its benefits. Coronary artery calcification poses challenges for conventional angioplasty, making cutting balloon angioplasty a preferred option. The device's microsurgical metal blades effectively incise calcifications during dilation, leading to better luminal gain and reduced risks of restenosis and stent thrombosis.
Clinical studies suggest that cutting balloon angioplasty demonstrates superiority over conventional methods in terms of acute luminal gain and reduced target vessel revascularization incidence. Despite concerns about the risk of artery lesion tear, advancements in technology and improved procedural techniques are expected to address such issues.
In conclusion, the cutting balloon market has evolved significantly, showcasing its efficacy in handling complex calcified artery lesions. The market is poised for continued growth in the coming years, driven by increased acceptance within the medical community and ongoing advancements in technology that mitigate potential complications.
Owed to the above factors, the global market is projected to grow at a CAGR of 5.6% in the forecasted period.
The provider of cutting balloons has significant opportunities in the field of coronary intervention. When dealing with patients suffering from acute coronary syndrome (ACS) and having dense blockages, there is a frequent need for preliminary widening before inserting stents. Utilizing cutting balloons (CBs) can yield superior immediate results compared to alternative scoring balloons, thereby minimizing the chances of particles breaking loose and causing complications downstream.
The innovative Wolverine cutting balloon has shown promising results in treating calcified coronary lesions, offering a potential solution to the challenges posed by calcification during angioplasty. Additionally, the study's focus on investigating the appropriate balloon-to-artery ratio (BAR) for CBs presents an opportunity to enhance procedural precision and reduce the risk of complications.
The adoption of cutting balloons in combination with drug-coated balloons (DCBs) for in-stent restenosis (ISR) lesions also opens avenues for improved patient outcomes. The study's findings suggest that combining cutting balloon angioplasty (CBA) with DCBs could lead to better results in lowering the recurrence of ISR. Moreover, the study's exploration of in-stent dilation in circumferential coronary calcifications using cutting balloons presents a breakthrough in addressing challenges associated with heavy coronary calcification during stent implantation.
These opportunities underscore the potential of cutting balloons to advance coronary intervention techniques, enhance procedural success rates, and ultimately improve patient care. The utilization of cutting balloons, particularly the innovative Wolverine model, demonstrates the service provider's commitment to delivering effective solutions for complex coronary conditions, making a significant impact in the field of interventional cardiology.
Principal Consultant
The demand for cutting balloons is influenced by several factors. Cost is a major barrier, as cutting balloons requires advanced technology and specialized training for medical professionals. Alternative treatments like traditional balloon angioplasty or stent placement are more cost-effective and less invasive. The risk of complications is another concern, as physicians and patients may opt for less risky options.
Cutting balloons are primarily used for specific cases involving calcified or tough lesions, potentially reducing their demand. Regulatory hurdles, lack of awareness among patients and healthcare providers, preference for drug-eluting stents, and inadequate healthcare infrastructure also contribute to the market's restraint. These factors collectively hinder the adoption of cutting balloons, impacting their market growth and adoption within the medical industry.
| Country | Value CAGR |
|---|---|
| United States | 5.4% |
| Germany | 4.8% |
| United Kingdom | 4.4% |
| Japan | 5.9% |
| China | 5.3% |
| India | 4.5% |
The United States occupied a 38.6% value share in the global market in 2022, and expenditure on cutting balloons in 2022 was US$ 154.3 Million.
The United States stands out as a prominent market for cutting balloons in the North American region due to the high prevalence of acute coronary syndrome (ACS) and coronary heart disease (CHD). With CHD accounting for a significant portion of deaths, ACS is a symptomatic form that demands effective treatment.
Consequently, the United States' high incidence of heart disease and chest pain-related emergency visits positions it as a key market for cutting balloon technologies.
Germany occupies a 40.3% value share in Europe in 2022, and expenditure on cutting balloons in 2022 was US$ 34.3 Billion.
Despite challenges in coordinating inpatient and outpatient care, there is a recognized need for multidisciplinary approaches, including discharge planning, lifestyle guidance, monitoring, and self-care. To address these complexities, a disease management program is set to be introduced in Germany in 2018, reflecting the country's commitment to enhancing cardiac care and making it an attractive market for cutting balloons.
In 2022, Japan held a dominant global revenue in the East Asian market and contributed around US$ 33.8 Million.
Japan's attractiveness as a highly lucrative market for cutting balloons stems from its remarkable longevity achievements.
A significant reduction in cardiovascular disease-related mortality, particularly stroke, has played a pivotal role. The prevalence of small vessel disease (arteriolosclerosis) in Japan aligns with its disease profile, mirrored in certain regions of central Asia and Africa. The decline in high blood pressure rates, coupled with improved emergency care and preventive measures, has driven these health outcomes.
To combat emerging risks like ischemic heart disease, Japan is compelled to pioneer innovative models for cardiovascular disease prevention and control, addressing chronic ailments and promoting overall health.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Market Growth Outlook by Key Products
| Products | Value CAGR |
|---|---|
| Drug-coated Cutting Balloons | 6.0% |
| Conventional Cutting Balloons | 5.4% |
| Scoring Balloons | 5.1% |
By product, drug-coated cutting balloons covered 42.1% of market shares in the world in 2022. The product predicted to rapidly expand between 2023 and 2033 is the Drug-coated balloon (DCB). With the rising prevalence of coronary artery disease (CAD), DCB treatment presents a revolutionary approach.
By delivering anti-proliferative drugs directly to vessel walls, DCB treatment offers advantages like reduced reliance on stents, immediate drug release, and potential reduction in antiplatelet therapy duration. Its applications extend to various coronary diseases, including restenosis, small vessel disease, and chronic occlusion. Multiple trials have validated its efficacy, positioning DCB as an innovative solution for CAD treatment, making it poised for rapid expansion in the coming decade.
Market Growth Outlook by Key Applications
| Application | Value CAGR |
|---|---|
| Coronary Artery Disease | 5.2% |
| Peripheral Artery Disease | 6.2% |
The market value of coronary artery disease in cutting balloons is US$ 234.1 Million, representing a sizable 58.5% market share in 2022. Cutting balloons have gained favor as a preferred choice for treating Coronary Artery Disease (CAD) due to their efficacy in addressing atherosclerotic plaque obstruction. CAD, characterized by impaired blood flow and oxygen delivery, contributes significantly to morbidity and mortality.
Cutting balloons mitigates this by utilizing microsurgical blades during balloon inflation, enabling precise plaque modification without extensive vessel trauma. This approach minimizes complications like dissections, enhancing procedural success. Given CAD's global burden and economic impact, cutting balloons offers a tailored solution to restore blood flow, reduce symptoms, and improve patient outcomes, making them a valuable tool in CAD management.
Market Growth Outlook by Key End Users
| End User | Value CAGR |
|---|---|
| Hospitals | 5.8% |
| Cardiac Centers | 5.3% |
| Ambulatory Surgical Centers | 5.6% |
The hospitals have a considerable presence in the cutting balloons market, accounting for 45.8% of end users in 2022, and exhibiting a high CAGR of 5.8% over the forecast period. The key end consumers of the global coronary artery disease market are hospitals. Hospitals are essential healthcare facilities that are crucial in the detection, treatment, and management of coronary artery disease (CAD). They provide a wide range of therapies for CAD patients, such as diagnostic procedures, surgical interventions, and rehabilitation programs.
Modern medical technology, experienced cardiologists, and interdisciplinary teams are all found in hospitals, providing efficient patient care and illness control. Hospitals are crucial recipients of developments and innovations in the worldwide coronary artery disease market because of their central role in the treatment of CAD; this improves patient outcomes and boosts the effectiveness of healthcare as a whole.
Advancements and partnerships within healthcare providers, research institutes, and tech enterprises foster cutting-edge innovation. Collaborative efforts boost market growth and diversify applications. Several prominent companies vie in the cutting balloon sector, including:
Similarly, recent developments related to the company’s manufacturing the cutting balloons have been tracked by the team at Future Market Insights, which are available in the full report.
Related Market Growth Outlook Scenario
| Particulars | Value CAGR |
|---|---|
| Angiography Devices Market | 6.2% |
| Angiographic Catheters Market | 4.3% |
| Peripheral Angioplasty Market | 7.7% |
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa. |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The global market is worth USD 400.2 Million in 2022.
The global market estimate for 2023 is around USD 421.2 Million.
The global market is expected to reach USD 725.9 Million by the end of 2033
The global market grew at a CAGR of 3.8% between 2017 and 2022.
The United States contributed around USD 154.3 Million in the year 2022.
Germany holds nearly 8.6% market share in the global market in 2022.
Japan accounted for a market value share of around 8.4% in 2022 globally.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption/Usage Analysis 4.2. Products USP/ Features Analysis 4.3. Regulatory Landscape 4.3.1. Regulatory Frameworks in United States 4.3.2. Regulatory Frameworks in Europe 4.3.3. Regulatory Frameworks in India 4.3.4. Regulatory Frameworks in Australia 4.4. Porter’s Analysis 4.5. PESTLE Analysis 4.6. Value Chain Analysis 4.7. Unmet Needs 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Expenditure 5.1.2. Global Life Expectancy Market Outlook 5.1.3. Research and Development funding by Region 5.1.4. Global Breast Imaging Market Overview – Parent Market Analysis 5.2. Forecast Factors - Relevance and Impact 5.2.1. Top Companies Historical Growth 5.2.2. Increased Prevalence of Chronic Diseases 5.2.3. Technological Advancements in Molecular Diagnostics 5.2.4. New Product Launches 5.2.5. Increasing Focus on Cancer Diagnostics 5.2.6. Strategic Collaborations and Partnerships 5.2.7. Cost of Product 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand (in Volume) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Volume (Units) Analysis, 2017 to 2022 6.2. Current and Future Market Volume (Units) Analysis and Forecast, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market – Pricing Assessment 7.1. Regional Pricing Analysis 7.2. Pricing Break-up 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 8.2. Current and Future Market Size (US$ Million) Analysis and Forecast, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033 9.3.1. Drug-coated Cutting Balloons 9.3.2. Conventional Cutting Balloons 9.3.3. Scoring Balloons 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 10.3.1. Coronary Artery Disease 10.3.2. Peripheral Artery Disease 10.4. Market Attractiveness Analysis By Application 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 11.3.1. Hospitals 11.3.2. Cardiac Centers 11.3.3. Ambulatory Surgical Centers 11.4. Market Attractiveness Analysis By End User 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East and Africa 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. United States 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By Application 13.3.4. By End User 13.4. Market Attractiveness Analysis By Region 13.4.1. By Country 13.4.2. By Product 13.4.3. By Application 13.4.4. By End User 13.5. Market trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 13.8. Country Level Analysis and Forecast 13.8.1. United States Market Analysis 13.8.1.1. Introduction 13.8.1.2. Market Analysis and Forecast by Market Taxonomy 13.8.1.2.1. By Product 13.8.1.2.2. By Application 13.8.1.2.3. By End User 13.8.2. Canada Market Analysis 13.8.2.1. Introduction 13.8.2.2. Market Analysis and Forecast by Market Taxonomy 13.8.2.2.1. By Product 13.8.2.2.2. By Application 13.8.2.2.3. By End User 14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis By Region 14.4.1. By Country 14.4.2. By Product 14.4.3. By Application 14.4.4. By End User 14.5. Market trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis and Forecast 14.8.1. Brazil Market Analysis 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Product 14.8.1.2.2. By Application 14.8.1.2.3. By End User 14.8.2. Mexico Market Analysis 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Product 14.8.2.2.2. By Application 14.8.2.2.3. By End User 14.8.3. Argentina Market Analysis 14.8.3.1. Introduction 14.8.3.2. Market Analysis and Forecast by Market Taxonomy 14.8.3.2.1. By Product 14.8.3.2.2. By Application 14.8.3.2.3. By End User 15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. United Kingdom 15.3.1.2. Germany 15.3.1.3. Italy 15.3.1.4. France 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. BENELUX 15.3.1.8. Rest of Europe 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 15.4. Market Attractiveness Analysis By Region 15.4.1. By Country 15.4.2. By Product 15.4.3. By Application 15.4.4. By End User 15.5. Market trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis and Forecast 15.8.1. United Kingdom Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By Application 15.8.1.2.3. By End User 15.8.2. Germany Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By Application 15.8.2.2.3. By End User 15.8.3. Italy Market Analysis 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Product 15.8.3.2.2. By Application 15.8.3.2.3. By End User 15.8.4. France Market Analysis 15.8.4.1. Introduction 15.8.4.2. Market Analysis and Forecast by Market Taxonomy 15.8.4.2.1. By Product 15.8.4.2.2. By Application 15.8.4.2.3. By End User 15.8.5. Spain Market Analysis 15.8.5.1. Introduction 15.8.5.2. Market Analysis and Forecast by Market Taxonomy 15.8.5.2.1. By Product 15.8.5.2.2. By Application 15.8.5.2.3. By End User 15.8.6. Russia Market Analysis 15.8.6.1. Introduction 15.8.6.2. Market Analysis and Forecast by Market Taxonomy 15.8.6.2.1. By Product 15.8.6.2.2. By Application 15.8.6.2.3. By End User 15.8.7. BENELUX Market Analysis 15.8.7.1. Introduction 15.8.7.2. Market Analysis and Forecast by Market Taxonomy 15.8.7.2.1. By Product 15.8.7.2.2. By Application 15.8.7.2.3. By End User 16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction / Key Findings 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Indonesia 16.3.1.3. Thailand 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By Application 16.3.4. By End User 16.4. Market Attractiveness Analysis By Region 16.4.1. By Country 16.4.2. By Product 16.4.3. By Application 16.4.4. By End User 16.5. Market trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis and Forecast 16.8.1. India Market Analysis 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By Application 16.8.1.2.3. By End User 16.8.2. Indonesia Market Analysis 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By Application 16.8.2.2.3. By End User 16.8.3. Thailand Market Analysis 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Product 16.8.3.2.2. By Application 16.8.3.2.3. By End User 16.8.4. Malaysia Market Analysis 16.8.4.1. Introduction 16.8.4.2. Market Analysis and Forecast by Market Taxonomy 16.8.4.2.1. By Product 16.8.4.2.2. By Application 16.8.4.2.3. By End User 17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction / Key Findings 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By Application 17.3.4. By End User 17.4. Market Attractiveness Analysis By Region 17.4.1. By Country 17.4.2. By Product 17.4.3. By Application 17.4.4. By End User 17.5. Market trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis and Forecast 17.8.1. China Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By Application 17.8.1.2.3. By End User 17.8.2. Japan Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By Application 17.8.2.2.3. By End User 17.8.3. South Korea Market Analysis 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By Application 17.8.3.2.3. By End User 18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction / Key Findings 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By Application 18.3.4. By End User 18.4. Market Attractiveness Analysis By Region 18.4.1. By Country 18.4.2. By Product 18.4.3. By Application 18.4.4. By End User 18.5. Market trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis and Forecast 18.8.1. Australia Market Analysis 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By Application 18.8.1.2.3. By End User 18.8.2. New Zealand Market Analysis 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By Application 18.8.2.2.3. By End User 19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction / Key Findings 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Türkiye 19.3.1.3. South Africa 19.3.1.4. Northern Africa 19.3.1.5. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By Application 19.3.4. By End User 19.4. Market Attractiveness Analysis By Region 19.4.1. By Country 19.4.2. By Product 19.4.3. By Application 19.4.4. By End User 19.5. Market trends 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country Level Analysis and Forecast 19.8.1. GCC Countries Market Analysis 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Product 19.8.1.2.2. By Application 19.8.1.2.3. By End User 19.8.2. Türkiye Market Analysis 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Product 19.8.2.2.2. By Application 19.8.2.2.3. By End User 19.8.3. South Africa Market Analysis 19.8.3.1. Introduction 19.8.3.2. Market Analysis and Forecast by Market Taxonomy 19.8.3.2.1. By Product 19.8.3.2.2. By Application 19.8.3.2.3. By End User 19.8.4. Northern Africa Market Analysis 19.8.4.1. Introduction 19.8.4.2. Market Analysis and Forecast by Market Taxonomy 19.8.4.2.1. By Product 19.8.4.2.2. By Application 19.8.4.2.3. By End User 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players (%) 20.3. Market Concentration 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Deep Dive 21.2.1. Abbott 21.2.1.1. Overview 21.2.1.2. Product Portfolio 21.2.1.3. Key Financials 21.2.1.4. Sales Footprint 21.2.1.5. SWOT Analysis 21.2.1.6. Strategy Overview 21.2.1.6.1. Marketing Strategies 21.2.1.6.2. Product Strategies 21.2.1.6.3. Channel Strategies 21.2.2. Boston Scientific Corporation 21.2.2.1. Overview 21.2.2.2. Product Portfolio 21.2.2.3. Key Financials 21.2.2.4. Sales Footprint 21.2.2.5. SWOT Analysis 21.2.2.6. Strategy Overview 21.2.2.6.1. Marketing Strategies 21.2.2.6.2. Product Strategies 21.2.2.6.3. Channel Strategies 21.2.3. B. Braun Melsungen AG 21.2.3.1. Overview 21.2.3.2. Product Portfolio 21.2.3.3. Key Financials 21.2.3.4. Sales Footprint 21.2.3.5. SWOT Analysis 21.2.3.6. Strategy Overview 21.2.3.6.1. Marketing Strategies 21.2.3.6.2. Product Strategies 21.2.3.6.3. Channel Strategies 21.2.4. Cook Medical 21.2.4.1. Overview 21.2.4.2. Product Portfolio 21.2.4.3. Key Financials 21.2.4.4. Sales Footprint 21.2.4.5. SWOT Analysis 21.2.4.6. Strategy Overview 21.2.4.6.1. Marketing Strategies 21.2.4.6.2. Product Strategies 21.2.4.6.3. Channel Strategies 21.2.5. Cordis 21.2.5.1. Overview 21.2.5.2. Product Portfolio 21.2.5.3. Key Financials 21.2.5.4. Sales Footprint 21.2.5.5. SWOT Analysis 21.2.5.6. Strategy Overview 21.2.5.6.1. Marketing Strategies 21.2.5.6.2. Product Strategies 21.2.5.6.3. Channel Strategies 21.2.6. Medtronic 21.2.6.1. Overview 21.2.6.2. Product Portfolio 21.2.6.3. Key Financials 21.2.6.4. Sales Footprint 21.2.6.5. SWOT Analysis 21.2.6.6. Strategy Overview 21.2.6.6.1. Marketing Strategies 21.2.6.6.2. Product Strategies 21.2.6.6.3. Channel Strategies 21.2.7. MicroPort Scientific Corporation 21.2.7.1. Overview 21.2.7.2. Product Portfolio 21.2.7.3. Key Financials 21.2.7.4. Sales Footprint 21.2.7.5. SWOT Analysis 21.2.7.6. Strategy Overview 21.2.7.6.1. Marketing Strategies 21.2.7.6.2. Product Strategies 21.2.7.6.3. Channel Strategies 21.2.8. Opto Circuits (India) Ltd. 21.2.8.1. Overview 21.2.8.2. Product Portfolio 21.2.8.3. Key Financials 21.2.8.4. Sales Footprint 21.2.8.5. SWOT Analysis 21.2.8.6. Strategy Overview 21.2.8.6.1. Marketing Strategies 21.2.8.6.2. Product Strategies 21.2.8.6.3. Channel Strategies 21.2.9. Spectranetics (Philips Healthcare) 21.2.9.1. Overview 21.2.9.2. Product Portfolio 21.2.9.3. Key Financials 21.2.9.4. Sales Footprint 21.2.9.5. SWOT Analysis 21.2.9.6. Strategy Overview 21.2.9.6.1. Marketing Strategies 21.2.9.6.2. Product Strategies 21.2.9.6.3. Channel Strategies 21.2.10. Terumo Corporation 21.2.10.1. Overview 21.2.10.2. Product Portfolio 21.2.10.3. Key Financials 21.2.10.4. Sales Footprint 21.2.10.5. SWOT Analysis 21.2.10.6. Strategy Overview 21.2.10.6.1. Marketing Strategies 21.2.10.6.2. Product Strategies 21.2.10.6.3. Channel Strategies 21.2.11. TriReme Medical, LLC (QT Vascular Ltd.) 21.2.11.1. Overview 21.2.11.2. Product Portfolio 21.2.11.3. Key Financials 21.2.11.4. Sales Footprint 21.2.11.5. SWOT Analysis 21.2.11.6. Strategy Overview 21.2.11.6.1. Marketing Strategies 21.2.11.6.2. Product Strategies 21.2.11.6.3. Channel Strategies 21.2.12. Vascular Concepts Limited 21.2.12.1. Overview 21.2.12.2. Product Portfolio 21.2.12.3. Key Financials 21.2.12.4. Sales Footprint 21.2.12.5. SWOT Analysis 21.2.12.6. Strategy Overview 21.2.12.6.1. Marketing Strategies 21.2.12.6.2. Product Strategies 21.2.12.6.3. Channel Strategies 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Cutting Balloons Market
